Y‐box binding protein‐1 promotes tumorigenesis and progression via the epidermal growth factor receptor/AKT pathway in spinal chordoma

Chordomas are rare bone tumors with a poor prognosis and no approved targeted therapy. Y‐box binding protein‐1 (YBX1) promotes tumor growth, invasion and drug resistance. However, the role of YBX1 in chordoma is unclear. In this study, we examined the expression of YBX1 using immunohistochemistry an...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Chen, Ma, Yunlong, Yong, Lei, Yang, Chenlong, Wang, Peng, Liu, Xiao, Zhu, Bin, Zhou, Hua, Liu, Xiaoguang, Liu, Zhongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317961/
https://www.ncbi.nlm.nih.gov/pubmed/30426615
http://dx.doi.org/10.1111/cas.13875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317961/
https://www.ncbi.nlm.nih.gov/pubmed/30426615
http://dx.doi.org/10.1111/cas.13875

Ejemplares similares